Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

ESOT Purchases

26 Oct 2021 07:00

RNS Number : 2513Q
W.H. Ireland Group PLC
26 October 2021
 

26 October 2021

 

WH Ireland Group Plc

 

("WH Ireland" or the "Company")

 

ESOT Purchases

The Directors have received notice that on 2 September 2021 the Company's Employee Share Option Trust ("ESOT"), the trustee for which is Sanne Fiduciary Services Limited ("Sanne"), acquired 50,000 Ordinary Shares in the Company (the "ESOT Purchase Shares") at a price of 54.86p per share. Sanne can acquire up to 50,000 Ordinary Shares each month pursuant to the terms of the ESOT Purchase Plan, the details of which are set out in the announcement of 18 May 2021. A monthly share purchase plan is currently in place.

The total number of shares now held by Sanne, as trustee of the ESOT, is 2,379,500 Ordinary Shares representing 3.83% of the total issued share capital of the Company ("ESOT Shares"). 

It is the intention that the ESOT Shares will be used to satisfy the awards of share options granted to employees of the Company (or for such other purposes as may be required of the Trust from time to time).

The notifications set out below are provided in accordance with the requirements of the Market Abuse Regulation.

1

Details of the PCA

a)

Name

Sanne Fiduciary Services Limited, as trustee for the WH Ireland Employee Share Option Trust

2

Reason for the notification

a)

Position/status

PCA of the Directors (as a connected trust)

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

WH Ireland Group plc

b)

LEI

213800HB9TO5O4WD6S66

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.5 pence each

 

GB0009241885

b)

Nature of the transaction

Acquisition of existing shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

54.86p

50,000

d)

Aggregated information

- Aggregated volume

 - Price

 

50,000

54.86p

e)

Date of the transaction

25 October 2021

f)

Place of the transaction

London Stock Exchange (XLON)

 

For further information please contact:

WH Ireland Group plc

www.whirelandplc.com

Phillip Wale, Chief Executive Officer

+44(0) 20 7220 1666

Canaccord Genuity Limited

www.canaccordgenuity.com

Andrew Potts / Tom Diehl

+44(0) 20 7523 8000

MHP Communications

whireland@mhpc.com

Reg Hoare / James Bavister

+44 (0) 20 3128 8793

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKABNPBDKKKB
Date   Source Headline
29th Mar 20127:00 amRNSNotice of AGM/Annual Report & Accounts
23rd Mar 20127:00 amRNSPreliminary Results
15th Mar 20128:27 amRNSHolding(s) in Company
7th Mar 20127:00 amRNSWH Ireland strengthens corporate broking team
29th Feb 20127:00 amRNSAcquisition of Client List from Pritchard
18th Jan 20124:24 pmRNSTreasury Stock and Total Voting Rights
1st Dec 20115:43 pmRNSDirector's Dealing
30th Nov 20119:11 amRNSTotal Voting Rights
28th Nov 201111:13 amRNSDirector's Dealing
28th Nov 20117:00 amRNSDirector dealing(s)
7th Nov 20114:38 pmRNSHolding(s) in Company
2nd Nov 20115:19 pmRNSEmployee share plans, director dealing(s) and TVR
11th Oct 20117:00 amRNSChange of Registered Office
31st Aug 20117:00 amRNSTotal Voting Rights
18th Aug 20114:11 pmRNSDirector's Dealing
5th Aug 20112:08 pmRNSAdditional Listing and Total Voting Rights
28th Jul 20113:14 pmRNSDirector/PDMR Shareholding
26th Jul 20118:18 amRNSHolding(s) in Company
21st Jul 20119:40 amRNSHolding(s) in Company
18th Jul 201110:35 amRNSInterim Report - Replacement
18th Jul 20119:00 amRNSInterim Report
18th Jul 20117:00 amRNSHalf Year Results
20th May 20119:14 amRNSDisposal
21st Apr 201111:00 amRNSResult of AGM
21st Apr 20117:00 amRNSAGM Statement
12th Apr 20113:11 pmRNSHolding(s) in Company
12th Apr 20111:28 pmRNSDirector/PDMR Shareholding
5th Apr 20118:01 amRNSDirector/PDMR Shareholding
28th Mar 20113:25 pmRNSHolding(s) in Company
10th Mar 201110:39 amRNSDirector/PDMR Shareholding
2nd Mar 201110:44 amRNSNotice of AGM
28th Feb 20117:00 amRNSTotal Voting Rights and Director Shareholdings
28th Feb 20117:00 amRNSFinal Results
23rd Feb 20117:00 amRNSDirector/PDMR Shareholding
7th Feb 20115:13 pmRNSHolding(s) in Company
31st Jan 20117:30 amRNSDirectorate Change
29th Nov 20104:20 pmRNSHolding(s) in Company
18th Nov 20103:52 pmRNSHolding(s) in Company
17th Nov 20109:57 amRNSHolding(s) in Company
12th Nov 20107:45 amRNSChange of Adviser
1st Nov 20107:00 amRNSBoard Appointment
18th Oct 201011:04 amRNSHolding(s) in Company
20th Sep 20102:00 pmRNSUpdate on appointment of new CEO
16th Sep 20109:26 amRNSHolding(s) in Company
14th Sep 20105:34 pmRNSHolding(s) in Company
9th Aug 201011:59 amRNSInterim Report posted on website
28th Jul 201012:31 pmRNSHolding(s) in Company
26th Jul 201010:20 amRNSDirector/PDMR Shareholding
23rd Jul 20107:00 amRNSHalf Year Results
23rd Jul 20107:00 amRNSAppointment of New CEO & Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.